Concepedia

Bhamini Rangnekar

BR

Statistics

Publications

5

Citations

159

H-Index

5

Active since

2018

Affiliations

University of Otago(Current)

University of South Australia

Virginia Commonwealth University

University of Auckland

Bhamini Rangnekar is an author at University of Otago specializing in medicine, pharmacology, and drug discovery.

Top concepts

Publications per year

2018–2019

5

Publications

5

The influence of surface active l-leucine and 1,2-dipalmitoyl-sn-glycero-3-phosphatidylcholine (DPPC) in the improvement of aerosolization of pyrazinamide and moxifloxacin co-spray dried powders

Basanth Babu Eedara, Bhamini Rangnekar, Colin Doyle et al. · International Journal of Pharmaceutics · 2018 · 53 citations

, , +3

Inhalable Dry Powder of Bedaquiline for Pulmonary Tuberculosis: In Vitro Physicochemical Characterization, Antimicrobial Activity and Safety Studies

Mohammad A. M. Momin, Bhamini Rangnekar, Shubhra Sinha et al. · Pharmaceutics · 2019 · 36 citations · Full text

Development and characterization of high payload combination dry powders of anti-tubercular drugs for treating pulmonary tuberculosis

Basanth Babu Eedara, Bhamini Rangnekar, Shubhra Sinha et al. · European Journal of Pharmaceutical Sciences · 2018 · 27 citations

, , +6

Bedaquiline containing triple combination powder for inhalation to treat drug-resistant tuberculosis

Bhamini Rangnekar, Mohammad A. M. Momin, Basanth Babu Eedara et al. · International Journal of Pharmaceutics · 2019 · 27 citations

, , +11

Development and validation of a RP-HPLC method for simultaneous quantification of bedaquiline (TMC207), moxifloxacin and pyrazinamide in a pharmaceutical powder formulation for inhalation

Mohammad A. M. Momin, Bhamini Rangnekar, Shyamal C. Das · Journal of Liquid Chromatography & Related Technologies · 2018 · 16 citations

, , +15

1–5 of 5